T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab
Many adverse reactions associated with immune checkpoint inhibitor (ICI) treatments are immunologically driven and may necessitate discontinuation of the ICI. Herein, we present a patient who had been administered the radio contrast media amidotrizoate multiple times without issue but who then devel...
Main Authors: | Munir Pirmohamed, Anna Olsson-Brown, Lorenzo Ressel, Sean Hammond, Joshua Gardner, Serat-E Ali, Paul Thomson, Carol Jolly, Dan Carr, Dean Naisbitt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-05-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/9/5/e002521.full |
Similar Items
-
In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs
by: Sean Hammond, et al.
Published: (2021-04-01) -
Drug Induced Hypersensitivity and the HLA Complex
by: Munir Pirmohamed, et al.
Published: (2010-12-01) -
Hypersensitivity Reactions to Multiple Iodinated Contrast Media
by: Inmaculada Doña, et al.
Published: (2020-09-01) -
Dilemma in the Diagnosis of Povidone-Iodine Hypersensitivity
by: Patil N, et al.
Published: (2016-01-01) -
Pharmacological prevention of delayed hypersensitivity reactions caused by iodinated contrast media
by: Jung-Hyun Kim, et al.
Published: (2021-07-01)